九源基因（02566）于2026年3月4日披露了截至2026年2月28日的股份变动月报表。公告显示，公司本月注册股本保持人民币245,398,800元不变，未有新增发行或注销事项。
本月内，公司H股总数维持109,096,785股，其中流通中的已发行股份由上月底的108,322,385股减少至105,214,385股，变化主要因回购3,108,000股H股所致。这些回购股份尚未注销，暂以库存股份形式持有，数量由774,400股增至3,882,400股。内资股与非上市外资股方面，数量分别保持105,302,015股与31,000,000股，均无变动。
购回与注销方面，2月份公司多次在香港市场回购H股，回购日期集中于2月2日至2月12日，价格区间约为每股港币9.817元至10.67元，合计回购数量3,108,000股，暂未注销。
公司同时确认并无可行权的股份期权、股份激励计划或可换股票据的新增或变动。截至本月末，九源基因（02566）整体股本总量保持稳定，已遵守香港联交所《上市规则》及相关法律法规。公告由联席公司秘书黄秀签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.